Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Heart Arrest D006323 13 associated lipids
Cystitis D003556 23 associated lipids
Cholecystitis D002764 8 associated lipids
HIV Infections D015658 20 associated lipids
Subacute Sclerosing Panencephalitis D013344 3 associated lipids
Dermatitis, Allergic Contact D017449 20 associated lipids
AIDS Dementia Complex D015526 4 associated lipids
Constriction, Pathologic D003251 8 associated lipids
Medulloblastoma D008527 22 associated lipids
Zellweger Syndrome D015211 39 associated lipids
Coronary Thrombosis D003328 7 associated lipids
Glomerulonephritis, Membranous D015433 6 associated lipids
Peripheral Vascular Diseases D016491 8 associated lipids
Bronchopulmonary Dysplasia D001997 4 associated lipids
Hypertension, Portal D006975 12 associated lipids
Atherosclerosis D050197 85 associated lipids
Leukemia-Lymphoma, Adult T-Cell D015459 25 associated lipids
Metabolic Syndrome D024821 44 associated lipids
Dyslexia D004410 3 associated lipids
Leukemia, Eosinophilic, Acute D015472 3 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Owen JS et al. An improved assay for platelet-activating factor using HPLC-tandem mass spectrometry. 2005 J. Lipid Res. pmid:15520455
Lemieux C et al. Angiopoietins can directly activate endothelial cells and neutrophils to promote proinflammatory responses. 2005 Blood pmid:15498854
Mishra RK et al. Differential dependence of eosinophil chemotactic responses on phosphoinositide 3-kinase (PI3K). 2005 Allergy pmid:16076309
Jin Y et al. Human resting CD16-, CD16+ and IL-2-, IL-12-, IL-15- or IFN-alpha-activated natural killer cells differentially respond to sphingosylphosphorylcholine, lysophosphatidylcholine and platelet-activating factor. 2005 Eur. J. Immunol. pmid:16078278
Meyer MC et al. Potential role for mast cell tryptase in recruitment of inflammatory cells to endothelium. 2005 Am. J. Physiol., Cell Physiol. pmid:16079184
Fernandes ES et al. Cytokines and neutrophils as important mediators of platelet-activating factor-induced kinin B1 receptor expression. 2005 Br. J. Pharmacol. pmid:16025141
Xie DS and Xie YT [Role of platelet activating factor in hepatorenal syndrome]. 2005 Zhong Nan Da Xue Xue Bao Yi Xue Ban pmid:16045031
Marathe GK et al. Ultraviolet B radiation generates platelet-activating factor-like phospholipids underlying cutaneous damage. 2005 J. Biol. Chem. pmid:16115894
Bazan HE Cellular and molecular events in corneal wound healing: significance of lipid signalling. 2005 Exp. Eye Res. pmid:15781273
Lin P et al. Lysophosphatidylcholine modulates neutrophil oxidant production through elevation of cyclic AMP. 2005 J. Immunol. pmid:15728511
Shimada T et al. Platelet-activating factor acts on cortisol secretion by perfused guinea-pig adrenals via calcium-/phospholipid-dependent mechanisms. 2005 J. Endocrinol. pmid:15684346
Yasu T et al. Activated leukocytes and endothelial cells enhance retention of ultrasound contrast microspheres containing perfluoropropane in inflamed venules. 2005 Int. J. Cardiol. pmid:15686774
Fell JM Neonatal inflammatory intestinal diseases: necrotising enterocolitis and allergic colitis. 2005 Early Hum. Dev. pmid:15707723
Schaloske RH et al. Molecular characterization of the lipopolysaccharide/platelet activating factor- and zymosan-induced pathways leading to prostaglandin production in P388D1 macrophages. 2005 Biochim. Biophys. Acta pmid:15708354
Mann NS and Leung JW Pathogenesis of esophageal rings in eosinophilic esophagitis. 2005 Med. Hypotheses pmid:15617859
Cheng L et al. Platelet-activating factor and prostaglandin E2 impair esophageal ACh release in experimental esophagitis. 2005 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:15890711
Qu XW et al. Tetrahydrobiopterin prevents platelet-activating factor-induced intestinal hypoperfusion and necrosis: Role of neuronal nitric oxide synthase. 2005 Crit. Care Med. pmid:15891335
Gilli UO et al. Human polymorphonuclear neutrophils are recruited by porcine chemokines acting on CXC chemokine receptor 2, and platelet-activating factor. 2005 Transplantation pmid:15912099
Park EJ et al. Dietary ganglioside decreases cholesterol content, caveolin expression and inflammatory mediators in rat intestinal microdomains. 2005 Glycobiology pmid:15917432
Owen JS et al. Stress-induced platelet-activating factor synthesis in human neutrophils. 2005 Biochim. Biophys. Acta pmid:15863359
Göggel R and Uhlig S The inositol trisphosphate pathway mediates platelet-activating-factor-induced pulmonary oedema. 2005 Eur. Respir. J. pmid:15863642
Martínez-Cócera C et al. Rupatadine 10 mg and cetirizine 10 mg in seasonal allergic rhinitis: a randomised, double-blind parallel study. 2005 J Investig Allergol Clin Immunol pmid:15864879
Fulkerson PC et al. CXCL9 inhibits eosinophil responses by a CCR3- and Rac2-dependent mechanism. 2005 Blood pmid:15802529
Tiemann U et al. Influence of ovarian steroid hormones or platelet-activating factor on mRNA of platelet-activating factor receptor in endometrial explant perfusion cultures from ovariectomized bovine. 2005 Prostaglandins Other Lipid Mediat. pmid:15967160
Lang KS et al. Mechanisms of suicidal erythrocyte death. 2005 Cell. Physiol. Biochem. pmid:15956782
Kita Y et al. A multiplex quantitation method for eicosanoids and platelet-activating factor using column-switching reversed-phase liquid chromatography-tandem mass spectrometry. 2005 Anal. Biochem. pmid:15958190
Fang YH et al. [Relationship between serum vWF and PAF in type 2 diabetic patients and diabetic nephropathy]. 2005 Di Yi Jun Yi Da Xue Xue Bao pmid:15958323
Vinson SM et al. Neutrophil adherence to bladder microvascular endothelial cells following platelet-activating factor acetylhydrolase inhibition. 2005 J. Pharmacol. Exp. Ther. pmid:15937147
Sumita C et al. Platelet activating factor induces cytoskeletal reorganization through Rho family pathway in THP-1 macrophages. 2005 FEBS Lett. pmid:16004986
Dong J et al. [Effect of platelet-activating factor on long-term potentiation in rat hippocampal slices]. 2005 Zhongguo Ying Yong Sheng Li Xue Za Zhi pmid:21171322
Ou-Yang XY et al. [Inhibitory effect of ginkgolide B on angiogenesis in chronic inflammation]. 2005 Yao Xue Xue Bao pmid:16011257
Estellés R et al. Effect of boldine, secoboldine, and boldine methine on angiotensin II-induced neutrophil recruitment in vivo. 2005 J. Leukoc. Biol. pmid:15944212
Zhao T and Bokoch GM Critical role of proline-rich tyrosine kinase 2 in reversion of the adhesion-mediated suppression of reactive oxygen species generation by human neutrophils. 2005 J. Immunol. pmid:15944312
McLarnon JG et al. Perturbations in calcium-mediated signal transduction in microglia from Alzheimer's disease patients. 2005 J. Neurosci. Res. pmid:15948178
Ozger S et al. Effects of platelet-activating factor on nitrergic transmission in rabbit corpus cavernosum. 2005 Int. J. Urol. pmid:15985080
Echazarreta AL et al. Lack of systemic oxidative stress during PAF challenge in mild asthma. 2005 Respir Med pmid:15823446
Cao HC et al. Determination of platelet-activating factor by reverse phase high-performance liquid chromatography and its application in viral hepatitis. 2005 World J. Gastroenterol. pmid:16437644
Asada Y [Inflammatory and immune responses in arterial thrombus formation]. 2005 Rinsho Ketsueki pmid:16447700
Kira J [Multiple sclerosis]. 2005 Rinsho Shinkeigaku pmid:16447761
Rubin BB et al. Cytosolic phospholipase A2-alpha is necessary for platelet-activating factor biosynthesis, efficient neutrophil-mediated bacterial killing, and the innate immune response to pulmonary infection: cPLA2-alpha does not regulate neutrophil NADPH oxidase activity. 2005 J. Biol. Chem. pmid:15475363
Zinchuk O et al. Direct action of platelet activating factor (PAF) induces eosinophil accumulation and enhances expression of PAF receptors in conjunctivitis. 2005 Mol. Vis. pmid:15735601
Lang PA et al. Stimulation of erythrocyte ceramide formation by platelet-activating factor. 2005 J. Cell. Sci. pmid:15741229
Sheppard FR et al. Clinically relevant osmolar stress inhibits priming-induced PMN NADPH oxidase subunit translocation. 2005 J Trauma pmid:15824651
Leveau P et al. Severity of pancreatitis-associated gut barrier dysfunction is reduced following treatment with the PAF inhibitor lexipafant. 2005 Biochem. Pharmacol. pmid:15826603
Connelly PW et al. Paraoxonase-1 does not reduce or modify oxidation of phospholipids by peroxynitrite. 2005 Free Radic. Biol. Med. pmid:15607900
Ivanov AI et al. Albumin is not an irreplaceable carrier for amphipathic mediators of thermoregulatory responses to LPS: compensatory role of alpha1-acid glycoprotein. 2005 Am. J. Physiol. Regul. Integr. Comp. Physiol. pmid:15576666
Denizot Y et al. Platelet-activating factor does not stimulate cAMP formation from immature forms of freshly isolated leukaemic blasts. 2005 Leuk. Lymphoma pmid:15621790
Meyer MC et al. Calcium-independent phospholipase A2 is regulated by a novel protein kinase C in human coronary artery endothelial cells. 2005 Am. J. Physiol., Cell Physiol. pmid:15643055
Granger J and Remick D Acute pancreatitis: models, markers, and mediators. 2005 Shock pmid:16374372
Wang CP et al. [Influence of platelet activating factor and its antagonist on portal hypertension associated with liver cirrhosis: an experiment with rats]. 2005 Zhonghua Yi Xue Za Zhi pmid:16409839
Milias GA et al. Effects of eccentric exercise-induced muscle injury on blood levels of platelet activating factor (PAF) and other inflammatory markers. 2005 Eur. J. Appl. Physiol. pmid:16151835
Hauser CJ et al. Non-specific effects of 4-chloro-m-cresol may cause calcium flux and respiratory burst in human neutrophils. 2005 Biochem. Biophys. Res. Commun. pmid:16168959
Kihara Y et al. Dual phase regulation of experimental allergic encephalomyelitis by platelet-activating factor. 2005 J. Exp. Med. pmid:16172262
Tian X and Bazan NG Neuroprotection by platelet-activating factor antagonism. 2005 Ann. N. Y. Acad. Sci. pmid:16179552
Zhang Q et al. Staphylococcal lipoteichoic acid inhibits delayed-type hypersensitivity reactions via the platelet-activating factor receptor. 2005 J. Clin. Invest. pmid:16184199
Pexa A and Deussen A Modulation of ecto-5'-nucleotidase by phospholipids in human umbilical vein endothelial cells (HUVEC). 2005 Naunyn Schmiedebergs Arch. Pharmacol. pmid:16200394
Karantonis HC et al. Synthesis and biological evaluation of novel steroid-modified ether phospholipids. 2005 Chem. Phys. Lipids pmid:16202400
Antonopoulou S et al. Bioactive polar lipids from Chroococcidiopsis sp. (Cyanobacteria). 2005 Comp. Biochem. Physiol. B, Biochem. Mol. Biol. pmid:16198133
Melo RC et al. Intragranular vesiculotubular compartments are involved in piecemeal degranulation by activated human eosinophils. 2005 Traffic pmid:16138901
Hu G et al. Isoflurane prevents platelets from enhancing neutrophil-induced coronary endothelial dysfunction. 2005 Anesth. Analg. pmid:16243978
Okumura N et al. Platelet-activating factor in human normal tears. 2005 Curr. Eye Res. pmid:16251126
Ko HM et al. Platelet-activating factor induces matrix metalloproteinase-9 expression through Ca(2+)- or PI3K-dependent signaling pathway in a human vascular endothelial cell line. 2005 FEBS Lett. pmid:16288746
Ward JR et al. Agonists of toll-like receptor (TLR)2 and TLR4 are unable to modulate platelet activation by adenosine diphosphate and platelet activating factor. 2005 Thromb. Haemost. pmid:16270639
Walz PH et al. Platelet function and association of bovine viral diarrhea virus with platelets of persistently infected cattle. 2005 Am. J. Vet. Res. pmid:16273905
Shargall Y et al. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part VI: treatment. 2005 J. Heart Lung Transplant. pmid:16210120
Marrache AM et al. Intracellular signaling of lipid mediators via cognate nuclear G protein-coupled receptors. 2005 Jan-Apr Endothelium pmid:16036317
Krasheninnikov ME and Pliashkevich IuG [Effects of the platelet activating factor on the proliferation and IgE secretion by U-266BL human myeloma cells]. 2005 Jul-Aug Eksp Klin Farmakol pmid:16193656
O'Neill C The role of paf in embryo physiology. 2005 May-Jun Hum. Reprod. Update pmid:15790601
Louis NA et al. Lipid mediator networks and leukocyte transmigration. 2005 Sep-Oct Prostaglandins Leukot. Essent. Fatty Acids pmid:15979294
Spitzer AL et al. Early nonenhanced abdominal computed tomography can predict mortality in severe acute pancreatitis. 2005 Sep-Oct J. Gastrointest. Surg. pmid:16137586
Akyürek N et al. The effect of platelet activating factor antagonist BN 52021 on bacterial translocation and ICAM-I expression in experimental obstructive jaundice. 2005 Sep-Oct J Invest Surg pmid:16249168
Zheng P et al. Periodontal parameters and platelet-activating factor levels in serum and gingival crevicular fluid in a Chinese population. 2006 J. Clin. Periodontol. pmid:16970624
Tsoupras AB et al. Isolation and identification of hydroxyl-platelet-activating factor from natural sources. 2006 Life Sci. pmid:16860827
Woo HY et al. Mechanism for acute oral desensitization to antibiotics. 2006 Allergy pmid:16867049
Sallem W et al. Structure-activity relationships in platelet-activating factor. Part 14: synthesis and biological evaluation of piperazine derivatives with dual anti-PAF and anti-HIV-1 activity. 2006 Bioorg. Med. Chem. pmid:16908170
Fischer A et al. The ether lipid inositol-C2-PAF is a potent inhibitor of cell proliferation in HaCaT cells. 2006 Chembiochem pmid:16453359
Liu LR and Xia SH Role of platelet-activating factor in the pathogenesis of acute pancreatitis. 2006 World J. Gastroenterol. pmid:16489665
Spitzer AL et al. Applying Ockham's razor to pancreatitis prognostication: a four-variable predictive model. 2006 Ann. Surg. pmid:16495704
Biancone L et al. Platelet-activating factor synthesis and response on pancreatic islet endothelial cells: relevance for islet transplantation. 2006 Transplantation pmid:16495796
McMeekin SR et al. E-selectin permits communication between PAF receptors and TRPC channels in human neutrophils. 2006 Blood pmid:16514053
Ramirez R et al. Angiotensin II effect on hydraulic permeability: interaction with endothelin-1, nitric oxide, and platelet activating factor. 2006 J. Surg. Res. pmid:16515797
He P et al. Leukocyte-platelet aggregate adhesion and vascular permeability in intact microvessels: role of activated endothelial cells. 2006 Am. J. Physiol. Heart Circ. Physiol. pmid:16517944
Serradji N et al. Structure-activity relationships in platelet-activating factor. Part 13: synthesis and biological evaluation of piperazine derivatives with dual anti-PAF and anti-HIV-1 or pure antiretroviral activity. 2006 Bioorg. Med. Chem. pmid:16893650
Yang YP et al. Effect of increased hepatic platelet activating factor and its receptor portal hypertension in CCl4-induced liver cirrhosis. 2006 World J. Gastroenterol. pmid:16521183
Wang LJ et al. [Role of platelet activating factor in the injury of intestinal immuno-barrier function in young rats]. 2006 Zhongguo Dang Dai Er Ke Za Zhi pmid:16522243
Hong SH et al. Mitochondrial ligand inhibits store-operated calcium influx and COX-2 production in human microglia. 2006 J. Neurosci. Res. pmid:16547968
Hsu HC et al. Alpha-bulnesene, a novel PAF receptor antagonist isolated from Pogostemon cablin. 2006 Biochem. Biophys. Res. Commun. pmid:16712790
Mathonnet M et al. Platelet-activating factor in cirrhotic liver and hepatocellular carcinoma. 2006 World J. Gastroenterol. pmid:16718768
Cellai C et al. Growth inhibition and differentiation of human breast cancer cells by the PAFR antagonist WEB-2086. 2006 Br. J. Cancer pmid:16721373
Goldring WP and Pattenden G The phomactins. A novel group of terpenoid platelet activating factor antagonists related biogenetically to the taxanes. 2006 Acc. Chem. Res. pmid:16700534
Peng SY et al. Effect of ginkgolide B on the platelet-activating factor induced changes of chemotaxis and cytoskeleton of macrophages. 2006 Yao Xue Xue Bao pmid:16671547
Bate C et al. Platelet-activating factor antagonists protect amyloid-beta damaged neurons from microglia-mediated death. 2006 Neuropharmacology pmid:16678220
Faghiri Z and Bazan NG Selective relocalization and proteasomal downregulation of PKCalpha induced by platelet-activating factor in retinal pigment epithelium. 2006 Invest. Ophthalmol. Vis. Sci. pmid:16384990
Pégorier S et al. Oxidized phospholipid: POVPC binds to platelet-activating-factor receptor on human macrophages. Implications in atherosclerosis. 2006 Atherosclerosis pmid:16386258
Cui S et al. Effects of platelet-activating factor, thromboxane A2 and leukotriene D4 on isolated perfused rat liver. 2006 Prostaglandins Other Lipid Mediat. pmid:16846785
Menezes-de-Lima O et al. Lipoxin A4 inhibits acute edema in mice: implications for the anti-edematogenic mechanism induced by aspirin. 2006 Prostaglandins Other Lipid Mediat. pmid:16939877
Shao P et al. [Research on relationship of syndrome type and parameters of hemorheology and platelet activation in patients with acute gout arthritis of dampness-heat blockage type and stasis-heat accumulate type]. 2006 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:17186728
Karantonis HC et al. Effect of fast-food Mediterranean-type diet on type 2 diabetics and healthy human subjects' platelet aggregation. 2006 Diabetes Res. Clin. Pract. pmid:16236380
Wu J et al. Intestinal alkaline sphingomyelinase hydrolyses and inactivates platelet-activating factor by a phospholipase C activity. 2006 Biochem. J. pmid:16255717
Judge A et al. Hypersensitivity and loss of disease site targeting caused by antibody responses to PEGylated liposomes. 2006 Mol. Ther. pmid:16275098